These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4282906)

  • 1. Dissection of the immunosuppressive effect of the Fc region of tumor-enhancing IgG.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK; Scales RW; Shivers BR; Fields JF; Hester RB; Watson ES; Whitten HD
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):43-58. PubMed ID: 4282906
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
    Whitten HD; Cruse JM; Lewis GK; Watson ES
    J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
    [No Abstract]   [Full Text] [Related]  

  • 3. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific in vivo inhibition of macrophage receptors for cytophilic antibody by soluble immune complexes.
    Rao VS; Grodzicki RL; Mitchell MS
    Cancer Res; 1979 Jan; 39(1):174-82. PubMed ID: 761189
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors.
    Natvig JB; Gaarder PI; Turner MW
    Clin Exp Immunol; 1972 Oct; 12(2):177-84. PubMed ID: 4648819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synergistic immunosuppressive effect of endotoxin and PHA-M on immunologic enhancement in mice.
    Cruse JM; Forbes JT; Shivers BR; Gillespie GY; Lewis GK; Scales RW; Fields JF; Hester RB; Watson ES; Whitten HD
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):31-42. PubMed ID: 4282905
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 10. Papain hydrolysis products in four M-IgG subclasses.
    Snigurowicz J; Powiertowska-Rezmer M
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):265-73. PubMed ID: 7447639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of murine fibrosarcoma allografts and radiolabeled tumor-enhancing IgG2, normal (nonenhancing) IgG2 and bacterial endotoxin in endotoxin-tolerant and nontolerant mice.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Baldwin J; Porter M
    J Reticuloendothel Soc; 1974 Jan; 15(1):75-84. PubMed ID: 4810604
    [No Abstract]   [Full Text] [Related]  

  • 12. IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice.
    Wernersson S; Karlsson MC; Dahlström J; Mattsson R; Verbeek JS; Heyman B
    J Immunol; 1999 Jul; 163(2):618-22. PubMed ID: 10395649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged survival of murine fibrosarcoma allotransplants by anti-enhancing Fab alloantibody.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Hester RB; Fields JF
    Immunol Commun; 1972; 1(4):367-73. PubMed ID: 4548901
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of the immune response: III. The role of macrophages in the potentiation of the immune response by Fc fragments.
    Morgan EL; Weigle WO
    J Immunol; 1981 Apr; 126(4):1302-6. PubMed ID: 7204967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain.
    Raju TS; Scallon BJ
    Biochem Biophys Res Commun; 2006 Mar; 341(3):797-803. PubMed ID: 16442075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tumor-enhancing IgG2 on macrophage function.
    Cruse JM; Lewis R; Dilioglou S
    Exp Mol Pathol; 2004 Aug; 77(1):43-8. PubMed ID: 15215049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of irradiation and cyclophosphamide on anti-KLH antibody formation in mice.
    Hoffsten PE; Dixon FJ
    J Immunol; 1974 Feb; 112(2):564-72. PubMed ID: 4813901
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization with pseudorabies virus harboring Fc domain of IgG makes a contribution to protection of mice from lethal challenge.
    Takashima Y; Tsukamoto M; Ota H; Matsumoto Y; Hayashi Y; Otsuka H
    Vaccine; 2005 May; 23(29):3775-82. PubMed ID: 15893614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on antigenic competition. I. Antigenic competition between the Fc and Fab fragments of rabbit IgG in mice.
    Taussig MJ
    Immunology; 1971 Jul; 21(1):51-60. PubMed ID: 5558032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced changes in established tumor immunity.
    Vaage J; Doroshow JH; DuBois TT
    Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.